FOI release

Regulatory performance: MHRA New Active Substances Approval Timelines 2021–2025

Case reference FOI2026/00785

Received 20 July 2026

Published 9 September 2026

Request

See attached

Response

See attached

Documents

• FOI2026_00785 (redacted).pdf (856.7 KB)
• FOI2026_00785 New Actives (2021 - 2025) FINAL.pdf (235.2 KB)

This is Medicines and Healthcare products Regulatory Agency's response to a freedom of information (FOI) or environmental information regulations (EIR) request.

You can browse our other responses or make a new FOI request.